Free Trial

Alvotech (ALVO) Competitors

Alvotech logo
$9.02 -0.17 (-1.85%)
Closing price 04:00 PM Eastern
Extended Trading
$9.01 -0.01 (-0.11%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ALVO vs. QGEN, VTRS, ASND, MRNA, BBIO, BPMC, VRNA, ROIV, ELAN, and RVMD

Should you be buying Alvotech stock or one of its competitors? The main competitors of Alvotech include Qiagen (QGEN), Viatris (VTRS), Ascendis Pharma A/S (ASND), Moderna (MRNA), BridgeBio Pharma (BBIO), Blueprint Medicines (BPMC), Verona Pharma PLC American Depositary Share (VRNA), Roivant Sciences (ROIV), Elanco Animal Health (ELAN), and Revolution Medicines (RVMD). These companies are all part of the "pharmaceutical products" industry.

Alvotech vs. Its Competitors

QIAGEN (NYSE:QGEN) and Alvotech (NASDAQ:ALVO) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, dividends, valuation, media sentiment, earnings, risk, analyst recommendations and profitability.

QIAGEN has higher revenue and earnings than Alvotech. Alvotech is trading at a lower price-to-earnings ratio than QIAGEN, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
QIAGEN$1.98B5.34$83.59M$0.40118.73
Alvotech$491.98M5.53-$231.86M$0.3724.38

70.0% of QIAGEN shares are owned by institutional investors. 9.0% of QIAGEN shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Alvotech has a net margin of 16.42% compared to QIAGEN's net margin of 4.68%. QIAGEN's return on equity of 14.61% beat Alvotech's return on equity.

Company Net Margins Return on Equity Return on Assets
QIAGEN4.68% 14.61% 8.80%
Alvotech 16.42%-36.37%12.70%

In the previous week, Alvotech had 4 more articles in the media than QIAGEN. MarketBeat recorded 9 mentions for Alvotech and 5 mentions for QIAGEN. Alvotech's average media sentiment score of 0.97 beat QIAGEN's score of 0.33 indicating that Alvotech is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
QIAGEN
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Alvotech
3 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

QIAGEN has a beta of 0.68, meaning that its stock price is 32% less volatile than the S&P 500. Comparatively, Alvotech has a beta of 0.11, meaning that its stock price is 89% less volatile than the S&P 500.

QIAGEN currently has a consensus target price of $49.40, suggesting a potential upside of 4.02%. Alvotech has a consensus target price of $18.00, suggesting a potential upside of 99.56%. Given Alvotech's stronger consensus rating and higher probable upside, analysts plainly believe Alvotech is more favorable than QIAGEN.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
QIAGEN
0 Sell rating(s)
7 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.30
Alvotech
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

QIAGEN beats Alvotech on 9 of the 16 factors compared between the two stocks.

Get Alvotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALVO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALVO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ALVO vs. The Competition

MetricAlvotechMED IndustryMedical SectorNASDAQ Exchange
Market Cap$2.77B$2.92B$5.53B$9.03B
Dividend YieldN/A2.44%5.24%4.01%
P/E Ratio15.857.5519.3119.89
Price / Sales5.53284.29424.59117.07
Price / CashN/A41.7026.2128.59
Price / Book-6.587.397.925.55
Net Income-$231.86M-$55.04M$3.17B$248.49M
7 Day Performance-1.10%3.01%2.18%5.37%
1 Month Performance-15.38%-0.21%1.25%6.63%
1 Year Performance-25.58%4.48%33.90%21.20%

Alvotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ALVO
Alvotech
3.9863 of 5 stars
$9.02
-1.8%
$18.00
+99.6%
-24.2%$2.77B$491.98M15.851,032
QGEN
Qiagen
3.855 of 5 stars
$48.07
+0.6%
$49.40
+2.8%
+21.0%$10.62B$1.98B120.525,765Dividend Announcement
VTRS
Viatris
3.3418 of 5 stars
$8.93
-0.9%
$10.40
+16.5%
-10.4%$10.57B$14.74B-2.8232,000
ASND
Ascendis Pharma A/S
3.4707 of 5 stars
$172.60
+0.2%
$220.67
+27.8%
+28.2%$10.53B$393.54M-27.481,017Positive News
MRNA
Moderna
4.3621 of 5 stars
$27.59
+1.6%
$46.61
+68.9%
-74.2%$10.50B$3.24B-3.165,800Gap Up
BBIO
BridgeBio Pharma
4.668 of 5 stars
$43.18
-3.7%
$58.85
+36.3%
+69.7%$8.52B$221.90M-12.23400High Trading Volume
BPMC
Blueprint Medicines
1.3655 of 5 stars
$128.18
+0.1%
$128.06
-0.1%
+14.8%$8.27B$508.82M-51.89640
VRNA
Verona Pharma PLC American Depositary Share
2.7655 of 5 stars
$94.58
+0.8%
$101.10
+6.9%
+466.0%$7.99B$42.28M-47.2930Positive News
ROIV
Roivant Sciences
1.5092 of 5 stars
$11.27
-1.1%
$17.50
+55.3%
+1.8%$7.74B$29.05M-45.08860
ELAN
Elanco Animal Health
2.334 of 5 stars
$14.29
flat
$15.17
+6.1%
+3.0%$7.10B$4.44B19.319,000Analyst Upgrade
RVMD
Revolution Medicines
4.557 of 5 stars
$36.79
-0.3%
$67.58
+83.7%
-1.4%$6.88B$11.58M-9.20250Gap Up

Related Companies and Tools


This page (NASDAQ:ALVO) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners